• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immunohorizons . Mass Cytometry Defines Virus-Specific CD4 + T Cells in Influenza Vaccination

tetano

Editor, Senior Moderator
Immunohorizons


. 2020 Dec 11;4(12):774-788.
doi: 10.4049/immunohorizons.1900097.
Mass Cytometry Defines Virus-Specific CD4 [SUP]+[/SUP] T Cells in Influenza Vaccination


Priyanka B Subrahmanyam[SUP] 1 [/SUP], Tyson H Holmes[SUP] 1 [/SUP], Dongxia Lin[SUP] 1 [/SUP], Laura F Su[SUP] 1 [/SUP], Gerlinde Obermoser[SUP] 2 [/SUP], Jacques Banchereau[SUP] 3 [/SUP], Virginia Pascual[SUP] 2 [/SUP], Adolfo Garc?a-Sastre[SUP] 4 5 6 [/SUP], Randy A Albrecht[SUP] 4 [/SUP], Karolina Palucka[SUP] 2 [/SUP], Mark M Davis[SUP] 1 [/SUP], Holden T Maecker[SUP] 7 [/SUP]



Affiliations

Abstract

The antiviral response to influenza virus is complex and multifaceted, involving many immune cell subsets. There is an urgent need to understand the role of CD4[SUP]+[/SUP] T cells, which orchestrate an effective antiviral response, to improve vaccine design strategies. In this study, we analyzed PBMCs from human participants immunized with influenza vaccine, using high-dimensional single-cell proteomic immune profiling by mass cytometry. Data were analyzed using a novel clustering algorithm, denoised ragged pruning, to define possible influenza virus-specific clusters of CD4[SUP]+[/SUP] T cells. Denoised ragged pruning identified six clusters of cells. Among these, one cluster (Cluster 3) was found to increase in abundance following stimulation with influenza virus peptide ex vivo. A separate cluster (Cluster 4) was found to expand in abundance between days 0 and 7 postvaccination, indicating that it is vaccine responsive. We examined the expression profiles of all six clusters to characterize their lineage, functionality, and possible role in the response to influenza vaccine. Clusters 3 and 4 consisted of effector memory cells, with high CD154 expression. Cluster 3 expressed cytokines like IL-2, IFN-γ, and TNF-α, whereas Cluster 4 expressed IL-17. Interestingly, some participants had low abundance of Clusters 3 and 4, whereas others had higher abundance of one of these clusters compared with the other. Taken together, we present an approach for identifying novel influenza virus-reactive CD4[SUP]+[/SUP] T cell subsets, a method that could help advance understanding of the immune response to influenza, predict responsiveness to vaccines, and aid in better vaccine design.
 
Back
Top Bottom